choosing between isatuximab & daratumumab in multiple myeloma
Published 1 year ago • 2.2K plays • Length 4:01Download video MP4
Download video MP3
Similar videos
-
1:37
daratumumab vs isatuximab in the treatment of multiple myeloma
-
2:30
daratumumab and isatuximab in the treatment of multiple myeloma
-
1:52
analyzing isatuximab in quadruplet combinations in transplant-ineligible multiple myeloma
-
1:58
treatment options for patients with multiple myeloma who are resistant to daratumumab
-
0:52
the future of daratumumab in multiple myeloma
-
2:53
novel targets and dual-targeting approaches in myeloma
-
2:36
approaching a myeloma population becoming increasingly resistant to daratumumab
-
6:07
blood analysis in multiple myeloma
-
13:28
m-power ny | dr. saad usmani presents myeloma treatments: how do we treat myeloma?
-
4:58
how i treat smoldering multiple myeloma - irene ghobrial, md
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
4:22
optimizing treatment sequencing in multiple myeloma: daratumumab upfront versus subsequent lines
-
2:32
the safety and efficacy of isatuximab for r/r myeloma: insights from icaria-mm, ikema & candor
-
0:59
defining the origins of multiple myeloma
-
2:34
how should smoldering multiple myeloma be monitored?
-
0:49
genomic differences between smoldering and multiple myeloma
-
3:56
iv daratumumab in r/r myeloma: bodyweight analysis
-
2:20
isatuximab for multiple myeloma - promising results and next steps
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
2:17
mrd: a promising biomarker in multiple myeloma
-
1:01
car-t: myeloma toxicities
-
2:46
managing patients with high-risk myeloma